EVENITY

The mark consists of two partially folded yellow and gray ribbons facing each other, all above the gray stylized word EVENITY.

Mark For: EVENITY™ trademark registration is intended to cover the categories of pharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth. [all]

>The color(s) yellow and gray is/are claimed as a feature of the mark. The mark consists of two partially folded yellow and gray ribbons facing each other, all above the gray stylized word EVENITY.

Status

2023-08-18 UTC
⟳ Refresh

DEAD APPLICATION Refused Dismissed or Invalidated

Research	OneLook Acronym Finder
Serial Number	87108839
Mark Literal Elements	EVENITY
Mark Drawing Type	3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type	TRADEMARK
Standard Character Claim	No
Register	PRINCIPAL
Current Location	TMEG LAW OFFICE 102 - EXAMINING ATTORNEY ASSIGNED 2019-11-20
Basis	1(b)
Class Status	ACTIVE
Primary US Classes	006: Chemicals and Chemical Compositions 018: Medicines and Pharmaceutical Preparations 044: Dental, Medical and Surgical Appliances 046: Foods and Ingredients of Foods 051: Cosmetics and Toilet Preparations 052: Detergents and Soaps
Primary International Class	005 - Primary Class (Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use	No
Current Use	No
Intent To Use	Yes
Filed ITU	Yes
44D Filed	No
44E Current	No
66A Current	No
Current Basis	No
No Basis	No
Attorney Name	Timothy J. Gaul
Law Office Assigned	L20
Employee Name	AGOSTO, GISELLE MARIE

Timeline

(ABANDONED)
IC 005. US 006 018 044 046 051 052. G & S: Pharmaceutical preparations used for the treatment of osteoporosis, bone disorders, bone diseases, skeletal disorders and skeletal diseases; pharmaceutical preparations used for increasing bone density, bone formation and bone growth. FIRST USE: 20190416. FIRST USE IN COMMERCE: 20190416